Please enable Javascript!

20. November 2013, Koblenz

CompuGroup Medical reports third quarter 2013 results

Koblenz – November 20, 2013: CompuGroup Medical AG today presented the financial report for the third quarter of 2013. The company, one of the leading global providers of eHealth solutions, achieved revenue of EUR 111.4 million, compared to EUR 107.4 million in the third quarter 2012. This represents an increase of 4 percent. Consolidated EBITDA amounted to EUR 25.3 million, which is at the same level as last year.

The doctor and dental software business in Europe had a good third quarter with 9 percent year-on-year organic growth at constant exchange rates. The pharmacy software business also performed well, with product sales and order bookings reaching record highs at the Expopharm trade fair in Germany and the first time revenue contribution from the newly acquired pharmacy software business in Italy. Year-on-year organic growth in the hospital business was 7 percent, which is a significant improvement compared to the first half of the year.

For the business in the United States, the trend with declining revenue seen at the beginning of the year continued in the third quarter. On a positive note, the sales and order bookings in the United States were higher in the third quarter compared to the same period last year. As expected in Health Connectivity Services, changes in the regulatory environment in Germany reduced revenue in the third quarter by 4 percent compared to last year.

In terms of operating profit, consolidated EBITDA amounted to EUR 25.3 million compared to EUR 25.6 million in 2012. The operating margin of 23 percent was one percent point lower than last year.

“In the third quarter this year we have restored the profitability level achieved last year and we will continue to work hard to further improve our growth and earnings power in the coming periods“, stated Frank Gotthardt, CEO and Chairman of the Board of CompuGroup Medical AG.

CompuGroup Medical reaffirms the 2013 outlook presented in the financial report for the second quarter 2013 with full year group revenue expected to be in the range of EUR 458 million to EUR 463 million and operating income (EBITDA) expected to be in the range of EUR 97 million to EUR 100 million.

Conference Call for Journalists, Investors and Analysts:
The management board of CompuGroup Medical AG will go through the Q3 results at a conference for analysts and investors today at 12:00 hours CET.

You can participate in this conference call by dialing one of the following phone numbers:
+49 (0) 69 2 10 86 97 03 (Germany)
+44 (0) 16 16 01 89 02 (UK)
+1 (0) 21 53 05 44 95 (USA)
Participant code: 18 56 12 70

A presentation will be made available for download on the CompuGroup Medical website at . The presentation can also be viewed live at

About CompuGroup Medical AG
CompuGroup Medical is one of the leading eHealth companies in the world. Its software products are designed to support all medical and organizational activities in doctors’ offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical’s services are based on a unique customer base of over 385,000 doctors, dentists, hospitals, pharmacies and networks as well as other service providers. With locations in 19 countries and customers in 35 countries worldwide, CompuGroup Medical is the eHealth company with one of the highest coverage among eHealth service providers. Approximately 3,700 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

Contact for media representatives:
CompuGroup Medical AG
Meike Stärke

Consultant Press & Media
T +49 (0) 261 8000-6100
F +49 (0) 261 8000-3100


Contact Press

Please contact us if you have any questions or concerns.